A detailed history of Manufacturers Life Insurance Company, The transactions in Vericel Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 26,119 shares of VCEL stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,119
Previous 26,472 1.33%
Holding current value
$1.52 Million
Previous $1.21 Million 9.14%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$42.25 - $53.56 $14,914 - $18,906
-353 Reduced 1.33%
26,119 $1.1 Million
Q2 2024

Aug 14, 2024

BUY
$41.71 - $52.9 $56,517 - $71,679
1,355 Added 5.39%
26,472 $1.21 Million
Q1 2024

May 14, 2024

BUY
$32.52 - $52.33 $74,698 - $120,202
2,297 Added 10.07%
25,117 $1.31 Million
Q4 2023

Feb 13, 2024

SELL
$30.85 - $37.09 $12,494 - $15,021
-405 Reduced 1.74%
22,820 $812,000
Q3 2023

Nov 15, 2023

BUY
$31.69 - $39.25 $129,453 - $160,336
4,085 Added 21.34%
23,225 $778,000
Q2 2023

Aug 11, 2023

BUY
$29.0 - $38.37 $8,526 - $11,280
294 Added 1.56%
19,140 $719,000
Q1 2023

May 15, 2023

BUY
$23.85 - $31.34 $1,764 - $2,319
74 Added 0.39%
18,920 $554,000
Q4 2022

Aug 11, 2023

BUY
$17.65 - $27.37 $953 - $1,477
54 Added 0.29%
18,846 $496,000
Q4 2022

Feb 13, 2023

BUY
$17.65 - $27.37 $953 - $1,477
54 Added 0.29%
18,846 $496,000
Q3 2022

Aug 11, 2023

SELL
$22.62 - $32.54 $8,550 - $12,300
-378 Reduced 1.97%
18,792 $435,000
Q3 2022

Nov 03, 2022

SELL
$22.62 - $32.54 $8,550 - $12,300
-378 Reduced 1.97%
18,792 $436,000
Q2 2022

Aug 11, 2023

SELL
$22.88 - $39.45 $1,990 - $3,432
-87 Reduced 0.45%
19,170 $482,000
Q2 2022

Aug 15, 2022

SELL
$22.88 - $39.45 $1,990 - $3,432
-87 Reduced 0.45%
19,170 $483,000
Q1 2022

Aug 11, 2023

BUY
$31.69 - $43.29 $10,679 - $14,588
337 Added 1.78%
19,257 $736,000
Q1 2022

May 20, 2022

SELL
$31.69 - $43.29 $142,224 - $194,285
-4,488 Reduced 18.9%
19,257 $736,000
Q4 2021

Feb 16, 2022

SELL
$35.2 - $52.6 $633 - $946
-18 Reduced 0.08%
23,745 $933,000
Q3 2021

Nov 12, 2021

SELL
$46.35 - $59.75 $110,544 - $142,503
-2,385 Reduced 9.12%
23,763 $1.16 Million
Q2 2021

Aug 12, 2021

BUY
$47.2 - $67.81 $32,048 - $46,042
679 Added 2.67%
26,148 $1.37 Million
Q1 2021

May 03, 2021

SELL
$30.93 - $59.48 $46,642 - $89,695
-1,508 Reduced 5.59%
25,469 $1.42 Million
Q4 2020

Feb 12, 2021

BUY
$18.53 - $31.5 $11,340 - $19,278
612 Added 2.32%
26,977 $833,000
Q3 2020

Nov 09, 2020

SELL
$14.68 - $19.12 $8,103 - $10,554
-552 Reduced 2.05%
26,365 $489,000
Q2 2020

Aug 10, 2020

SELL
$8.5 - $15.82 $13,753 - $25,596
-1,618 Reduced 5.67%
26,917 $365,000
Q1 2020

May 15, 2020

BUY
$7.25 - $19.22 $15,478 - $41,034
2,135 Added 8.09%
28,535 $262,000
Q4 2019

Feb 14, 2020

SELL
$13.77 - $19.2 $14,403 - $20,083
-1,046 Reduced 3.81%
26,400 $459,000
Q3 2019

Nov 12, 2019

SELL
$14.93 - $19.83 $5,300 - $7,039
-355 Reduced 1.28%
27,446 $411,000
Q2 2019

Aug 14, 2019

SELL
$15.01 - $18.89 $12,833 - $16,150
-855 Reduced 2.98%
27,801 $525,000
Q1 2019

May 13, 2019

BUY
$16.23 - $20.29 $36,777 - $45,977
2,266 Added 8.59%
28,656 $502,000
Q4 2018

Feb 14, 2019

SELL
$10.77 - $18.44 $24,954 - $42,725
-2,317 Reduced 8.07%
26,390 $459,000
Q3 2018

Nov 14, 2018

BUY
$9.1 - $14.8 $837 - $1,361
92 Added 0.32%
28,707 $406,000
Q2 2018

Aug 14, 2018

BUY
$9.6 - $14.6 $260,841 - $396,696
27,171 Added 1881.65%
28,615 $278,000
Q1 2018

May 15, 2018

SELL
$5.7 - $12.3 $1,174 - $2,533
-206 Reduced 12.48%
1,444 $14,000
Q4 2017

Feb 08, 2018

SELL
$3.65 - $5.98 $3,233 - $5,298
-886 Reduced 34.94%
1,650 $9,000
Q3 2017

Nov 14, 2017

BUY
$3.0 - $6.0 $7,608 - $15,216
2,536
2,536 $15,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.75B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.